Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Thumbnail

Transcarotid Access: The Future of Non-femoral TAVR?

The transcarotid approach to TAVR is becoming more common, according to research presented at TVT.19.

Thumbnail

Outsourcing Is In: Developing & Integrating Cath Lab Best Practices & Standardization

Sponsored by Terumo

Sometimes a move in the right direction starts with a good hard look in the rearview mirror, then breaking it off to start anew with greater wisdom.

Thumbnail

Magnitude of industry payments to CV lab directors of great concern

Medical directors of cardiac catheterization and EP labs receive three to four times the amount of money from pharmaceutical companies and device manufacturers as other interventional cardiologists in the same zip code, according to a JAMA Internal Medicine study.

Thumbnail

TCT, VEITHsymposium partner to strengthen conference material

The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.

1st live transmission of robotic PCI performed in Europe

Corindus Vascular Robotics’ CorPath GRX system—the world’s only FDA-approved and CE-marked robotic platform for percutaneous coronary intervention (PCI) and peripheral vascular intervention—was used in the first-ever live transmission of a robotic PCI in Europe during this year's EuroPCR congress.

Thumbnail

Orsiro achieves lower target lesion failure, revascularization than thicker stents

Three-year results of the BIO-RESORT study, presented at EuroPCR this week in Paris, put Biotronik’s ultrathin Orsiro stent ahead of two other competitors in terms of target lesion failure and revascularization.

Thumbnail

Medical association releases consensus statement on intra-coronary imaging

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) has published a clinical guidance statement regarding the use of intra-coronary imaging (IC), sharing the document during its EuroPCR Annual Meeting, May 21-24 in Paris.

Thumbnail

Abbott’s tricuspid valve repair system finds success in TRILUMINATE study

Results from the TRILUMINATE study, presented this week at EuroPCR 2019 in Paris, suggest Abbott’s minimally invasive tricuspid valve repair system is an effective solution for patients with structural heart disease, reducing the severity of tricuspid regurgitation (TR) in more than 85% of test cases.